Initial preclinical work demonstrated that curcumin ameliorated hepatic steatosis by upregulating the expression of hepatic FXR and CYP7A1 and inhibiting the activity of LXRα (Yan et al., 2018b). The gene discussed is NR1H4; the disease is Hepatic steatosis.